Humans

Associations of General and Central Obesity with Cardiovascular Risk by Menopausal and MASLD Status

Figure 1. Flowchart of the participant recruitment process.
Open the figure at full size
Figure 1. Flowchart of the participant recruitment process.Flowchart of the participant recruitment process.Kim et al. · CC BY

Biomedicines

Abstract

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence increases during the menopausal transition, yet its interaction with obesity phenotypes in influencing cardiovascular disease (CVD) risk remains unclear.

The paper

Yonsei University

Biomedicines · 3 Sep 2026 · CC BY

doi.org/10.3390/biomedicines14091985PubMed 42792727

Related